A model of scarless human fetal wound repair is deficient in transforming growth factor beta.

[1]  M. Laregina,et al.  The expression of transforming growth factor type beta in fetal and adult rabbit skin wounds. , 1994, Journal of pediatric surgery.

[2]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges. , 1992 .

[3]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[4]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[5]  M. Ferguson,et al.  Immunohistochemical localization of growth factors in fetal wound healing. , 1991, Developmental biology.

[6]  I. K. Cohen,et al.  Transforming growth factor beta (TGF-β) induces fibrosis in a fetal wound model , 1988 .

[7]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Akhurst,et al.  Rapid induction and clearance of TGF beta 1 is an early response to wounding in the mouse embryo. , 1993, Developmental genetics.

[9]  M. Longaker,et al.  Scarless wound repair: a human fetal skin model. , 1992, Development.

[10]  M. Longaker,et al.  Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. , 1990, Journal of pediatric surgery.